Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108359703 | 10835970 | 3 | F | 20141112 | 20160920 | 20150219 | 20160923 | EXP | PHHY2015CA019954 | NOVARTIS | 75.11 | YR | F | Y | 0.00000 | 20160923 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108359703 | 10835970 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, YEARLY | D | 21817 | 5 | MG | SOLUTION FOR INJECTION | ||||||
| 108359703 | 10835970 | 2 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | D | 21817 | SOLUTION FOR INJECTION | ||||||||
| 108359703 | 10835970 | 3 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | D | 21817 | SOLUTION FOR INJECTION | ||||||||
| 108359703 | 10835970 | 4 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | D | 21817 | SOLUTION FOR INJECTION | ||||||||
| 108359703 | 10835970 | 5 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | D | 21817 | SOLUTION FOR INJECTION | ||||||||
| 108359703 | 10835970 | 6 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | D | 21817 | SOLUTION FOR INJECTION | ||||||||
| 108359703 | 10835970 | 7 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | D | 21817 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108359703 | 10835970 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108359703 | 10835970 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108359703 | 10835970 | Bone disorder | |
| 108359703 | 10835970 | Fall | |
| 108359703 | 10835970 | Feeling abnormal | |
| 108359703 | 10835970 | Wrist fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108359703 | 10835970 | 1 | 20090210 | 0 | ||
| 108359703 | 10835970 | 2 | 20100209 | 0 | ||
| 108359703 | 10835970 | 3 | 20110208 | 0 | ||
| 108359703 | 10835970 | 4 | 20120209 | 0 | ||
| 108359703 | 10835970 | 5 | 20130205 | 0 | ||
| 108359703 | 10835970 | 6 | 20140203 | 0 | ||
| 108359703 | 10835970 | 7 | 20150304 | 0 |